Grenå Tandlægeklinik I/S

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  4.1% 2.0% 2.1% 2.2% 1.7%  
Credit score (0-100)  50 68 65 65 71  
Credit rating  BBB A BBB BBB A  
Credit limit (kDKK)  0.0 0.5 0.2 0.2 4.7  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  8,807 9,089 8,733 9,018 9,416  
EBITDA  2,339 3,371 3,558 3,916 3,714  
EBIT  2,027 3,054 3,241 3,604 3,343  
Pre-tax profit (PTP)  1,937.4 2,991.8 3,197.3 3,579.3 3,335.7  
Net earnings  1,937.4 2,991.8 3,197.3 3,579.3 3,335.7  
Pre-tax profit without non-rec. items  1,937 2,992 3,197 3,579 3,336  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  1,175 957 740 529 1,022  
Shareholders equity total  -249 1,047 1,870 2,714 2,995  
Interest-bearing liabilities  3,144 1,608 856 291 0.0  
Balance sheet total (assets)  3,806 4,072 3,723 3,715 3,727  

Net Debt  3,118 1,584 648 -167 -273  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  8,807 9,089 8,733 9,018 9,416  
Gross profit growth  293.6% 3.2% -3.9% 3.3% 4.4%  
Employees  11 10 9 10 10  
Employee growth %  0.0% -9.1% -10.0% 11.1% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  3,806 4,072 3,723 3,715 3,727  
Balance sheet change%  -16.0% 7.0% -8.6% -0.2% 0.3%  
Added value  2,338.8 3,371.1 3,558.1 3,921.6 3,714.4  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -588 -635 -635 -623 22  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  2.0 3.0 4.0 5.0 5.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  23.0% 33.6% 37.1% 40.0% 35.5%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  47.3% 75.5% 83.3% 97.1% 90.1%  
ROI %  56.1% 100.6% 116.6% 126.1% 111.7%  
ROE %  94.8% 123.3% 219.2% 156.2% 116.9%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  -6.2% 25.7% 50.2% 73.1% 80.4%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  133.3% 47.0% 18.2% -4.3% -7.3%  
Gearing %  -1,261.7% 153.5% 45.8% 10.7% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  2.7% 3.2% 4.1% 5.7% 10.8%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  0.2 0.3 0.5 1.1 1.2  
Current Ratio  0.2 0.5 0.7 1.6 1.7  
Cash and cash equivalent  25.9 23.4 207.3 458.3 272.7  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -3,206.5 -1,511.4 -561.9 593.5 480.8  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  213 337 395 392 371  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  213 337 395 392 371  
EBIT / employee  184 305 360 360 334  
Net earnings / employee  176 299 355 358 334